Search Results for 'median cancer'

median cancer published presentations and documents on DocSlides.

Malawi Cancer Consortium Overview
Malawi Cancer Consortium Overview
by min-jolicoeur
Satish Gopal MD MPH. University . of Malawi Colle...
Sipuleucel -T Survival Benefit
Sipuleucel -T Survival Benefit
by calandra-battersby
Sipuleucel. -T was approved based on HR of 0.775 ...
Complex Cancer Late Effects Rehabilitation Service
Complex Cancer Late Effects Rehabilitation Service
by OneAndOnly
(. CCLERS) . Complex Cancer Late Effects Rehabilit...
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
by Soulmate
Andrew J Armstrong MD . ScM. FACP. National Allia...
ASCO 2012 Review Gynecologic Cancer
ASCO 2012 Review Gynecologic Cancer
by welnews
Nelson Teng, M.D., Ph.D.. Director, Gynecologic On...
 Game Plan Trends in ovarian cancer
Game Plan Trends in ovarian cancer
by alexa-scheidler
Diagnostic work-up. Treatment. The most commonly ...
Prostate Cancer Screening in 2013: Reports of its Death Are
Prostate Cancer Screening in 2013: Reports of its Death Are
by min-jolicoeur
Norm D. Smith, M.D.. Associate Professor. Co-Dire...
Managing Breast Cancer in the Genomic Era
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
Network Audit 2010
Network Audit 2010
by giovanna-bartolotta
Failure to Obtain Histological / Cytological . Co...
Best of ASCO GU Session Sandy Srinivas.MD
Best of ASCO GU Session Sandy Srinivas.MD
by experimentgoogle
Stanford University. Outline. Abstract #4. :. . I...
Myeloma: Symptoms to diagnosis
Myeloma: Symptoms to diagnosis
by samantha
Can we do better?. [Hospital name]. [Date]. What i...
Surgery for Metastatic Brain Tumor from Breast Cancer
Surgery for Metastatic Brain Tumor from Breast Cancer
by bella
Tanat Vaniyapong, MD. Neurosurgery Unit, Faculty o...
Median PFS: 2.6 months (95% CI, 1.7-3.5)
Median PFS: 2.6 months (95% CI, 1.7-3.5)
by ceila
Median PFS: 1.4 months (95% CI, 1.2-1.6) . Median ...
National data in surgery: LCCOP 2018(2016)
National data in surgery: LCCOP 2018(2016)
by isla
Doug West Audit Committee Chair, Society for Cardi...
Module 3:  Chronic Lymphocytic Leukemia
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Grou
Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Grou
by DancingDragonfly
Michael Chuong, M.D.. 1,2. , Smith . Apisarnthanar...
Best practice for chemotherapy for treatment of breast cancer
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Endocrine  resistance: molecular pathways and rational development of targeted therapies
Endocrine resistance: molecular pathways and rational development of targeted therapies
by spottletoefacebook
Grazia Arpino. UniversitĂ  di Napoli Federico II. ...
Andrew H. Ko, MD  University of California San Francisco
Andrew H. Ko, MD University of California San Francisco
by test
Gastrointestinal Oncology Program. Treatment of m...
“Critical & Terminal illness – moving to new Frontiers!”
“Critical & Terminal illness – moving to new Frontiers!”
by luanne-stotts
“How long have I got, doc?”. . -not . a ques...
How to describe a graph
How to describe a graph
by olivia-moreira
Otherwise called. CUSS. 5. In context. You must w...
Metastatic Breast Cancer
Metastatic Breast Cancer
by lindy-dunigan
A sub-focus on specific clinical scenarios. What ...
Btk  inhibition in Mantle cell Lymphoma & CLL
Btk inhibition in Mantle cell Lymphoma & CLL
by test
Simon Rule. Professor of Clinical . Haematology. ...
Adult  granulosa  cell  tumor
Adult granulosa cell tumor
by jamir
associated. with . breast. cancer in Denmark 196...
As it pertains to the last patient in your practice who died of metastatic nonsquamous
As it pertains to the last patient in your practice who died of metastatic nonsquamous
by kittie-lecroy
non-small cell lung cancer (NSCLC) . with no targ...
The Impending  D eath of Cancer: A Herculean Task Emerging Therapies 2016
The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016
by phoebe-click
The Impending D eath of Cancer: A Herculean Task...
Immuno-Oncology Dr. Michael Palumbo
Immuno-Oncology Dr. Michael Palumbo
by mofferro
April 18, 2018. Immuno-Oncology. Activating the im...
Thomas E. Keane  Medical University of South Carolina
Thomas E. Keane Medical University of South Carolina
by valerie
Charleston, SC. Bones, Hot Flashes, and ADT Use Wi...
Results of Phase II study of
Results of Phase II study of
by grace3
Durvalumab. in cancer patients with HIV-1 infecti...
Efficacy of  sorafenib  in patients with
Efficacy of sorafenib in patients with
by caitlin
desmoid. -type . fibromatosis. Rodrigo Munhoz. 1. ...
The Impending  D eath of Cancer:
The Impending D eath of Cancer:
by elina
A Herculean Task. Emerging Therapies 2016. Ruemu E...
Beth Sandy, MSN, CRNP Nurse Practitioner
Beth Sandy, MSN, CRNP Nurse Practitioner
by PriceOfFreedom
Abramson Cancer Center . University of Pennsylvani...
Vanessa A. Lukas  1 , MS4; Tim Craven
Vanessa A. Lukas 1 , MS4; Tim Craven
by eleanor
2. , . MSPH. ; Ashok K. Hemal. 1. , MD; Ram A. Pa...
nmCRPC  ASCO GU 2018 Bobby Shayegan, MD FRCSC
nmCRPC ASCO GU 2018 Bobby Shayegan, MD FRCSC
by kylie
Associate Professor & Head. David . Braley. &...
Case Discussion A 52-year-old man initially presented with
Case Discussion A 52-year-old man initially presented with
by lois-ondreau
nonmuscle. -invasive . bladder cancer. He receive...
Case Discussion: Second
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
Where we are with targeted
Where we are with targeted
by stefany-barnette
therapies . for . cholangiocarcinoma. Professor J...